China Health Technology Group Holding Co (HKSE:01069) EBIT : HK$8.72 Mil (TTM As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Health Technology Group Holding Co EBIT?

China Health Technology Group Holding Co's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$1.91 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$8.72 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Health Technology Group Holding Co's annualized ROC % for the quarter that ended in Jun. 2024 was -21.44%. China Health Technology Group Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 7.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Health Technology Group Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 4.72%.

China Health Technology Group Holding Co EBIT Historical Data

The historical data trend for China Health Technology Group Holding Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Technology Group Holding Co EBIT Chart

China Health Technology Group Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Jun22

Jun23

Jun24

EBIT

Get a 7-Day Free Trial

-216.40

-163.19

0.98

2.53

218.81

China Health Technology Group Holding Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT	Get a 7-Day Free Trial															8.62	-5.92	220.37	1.91	6.81

Competitive Comparison of China Health Technology Group Holding Co's EBIT

For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Technology Group Holding Co's EV-to-EBIT Distribution in the Forest Products Industry

For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Health Technology Group Holding Co's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

China Health Technology Group Holding Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$8.72 Mil.

China Health Technology Group Holding Co (HKSE:01069) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Health Technology Group Holding Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-33.84 * ( 1 - -0.33% )	/	( (141.994	+	174.699)	/ 2 )
=	-33.951672	/	158.3465
=	-21.44 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	154.702	-	11.054	-	( 1.654	-	max(0, 15.949	-	20.957	+	1.654	))
=	141.994

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	191.803	-	19.25	-	( 3.477	-	max(0, 53.09	-	50.944	+	3.477	))
=	174.699

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

China Health Technology Group Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	3.822	/	( ( (50.04 + max(-1.872, 0))	+	(46.875 + max(-3.429, 0)) )	/	2 )
=	3.822	/	( ( 50.04	+	46.875 )	/	2 )
=	3.822	/	48.4575
=	7.89 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.607	+	1.309	+	5.761)	-	(11.054	+	0	+	2.495)
=	-1.872

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(18.67	+	1.409	+	26.11)	-	(19.25	+	0	+	30.368)
=	-3.429

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Health Technology Group Holding Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	8.722	/	184.913
	=	4.72 %

China Health Technology Group Holding Co EBIT Related Terms

Thank you for viewing the detailed overview of China Health Technology Group Holding Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Technology Group Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » China Health Technology Group Holding Co Ltd (HKSE:01069) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Binhe Road South, Room 4101, Phase II Jingji Binhe Shidai Tower North, Futian District, Shenzhen, CHN

Website

http://www.caflc.co

China Health Technology Group Holding Co Ltd Formerly China Bozza Development Holdings Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has two reportable segments including the Forestry business; Horny Goat Weed Business; and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.

Executives

Huang Hou	2201 Interest of corporation controlled by you
Huang Hou	2101 Beneficial owner
Able Planet International Limited
China Bozza Scheme Limited
Arab Osman Mohammed
Lai Wing Lun
Wang Yue	2101 Beneficial owner
Long Yijia	2202 Interest of your spouse

China Health Technology Group Holding Co Headlines

No Headlines